1. Johnson & Johnson ( JNJ)

Yield: 4%

This diversified consumer health care giant has posted 27 straight years of earnings increases and 49 consecutive years of dividend hikes. In the past five years, sales have increased 4% annually to $61.6 billion, while earnings per share have grown 7% each year to $4.76 and dividends have risen 11% a year to $2.28 per share.

Johnson and Johnson

Product recalls of Tylenol and Motrin tarnished the company's reputation last year, but Johnson & Johnson appears to be on the rebound. The firm is benefiting from international expansion and a strong pharmaceutical pipeline, including Zytiga, a prostate-cancer treatment, and Xarelto, for stroke prevention. During the second quarter of 2011, Johnson & Johnson's sales improved 8.3% to $16.6 billion compared with the year-ago period, while earnings improved 5.8% year-over-year to $3.5 billion, or $1.28 per share.

Johnson & Johnson's financial strength is unsurpassed. The company has nearly $30 billion in cash, while debt sits at only $19 billion. Dividend payout ratio is conservative at 52%. The company trades at the same price-to-earnings ratio as the S&P (15), but offers a much better yield -- 3.6% compared with the index's 2.0% yield.

If you liked this article you might like

Tax Reform Is Coming and That Means Trump Stock Rally Is Ready to Kill It Again

How to Live Just Like Billionaire Warren Buffett

Microsoft's New Xbox One X Shows It's Done Trying to Please Everyone

'Trump Stock' Rally Is Back on Track

5 of the Worst Recent Cyberattacks